Enhancer of zeste homolog 2 (EZH2), a polycomb group histone methyltransferase, regulates the expression of estrogen responsive genes in breast and prostate cancer cells via its association with the repressor of estrogen activity (REA, Prohibitin 2), an estrogen receptor co-repressor34. The gene discussed is PRDM9; the disease is prostate cancer.